Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterations.
Spahr
L
L
Department of Neurology, University Hospital, Geneva, Switzerland.
Rubbia-Brandt
L
L
Burkhard
P R
PR
Assal
F
F
Hadengue
A
A
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D001577:Benzophenones / Q000009:adverse effects*; D065098:Catechol O-Methyltransferase Inhibitors; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced*; D008930:Mitochondria, Liver / Q000648:ultrastructure*; D009596:Nitrophenols; D000077867:Tolcapone
D000978:Antiparkinson Agents; D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D004791:Enzyme Inhibitors; D009596:Nitrophenols; D000077867:Tolcapone